An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
NCT00776659
·
clinicaltrials.gov ↗
TERMINATED
Status
39
Enrollment
INDUSTRY
Sponsor class
Stopped
See termination reason in detailed description.
Conditions
Breast Neoplasms
Interventions
OTHER:
Aromasin
Sponsor
Pfizer